DISCOUNT OPTIONSSCHEIN - CELSIUS HLDGS Stock

Certificat

DE000MG4CZX4

Real-time Bid/Ask 04:48:29 2024-07-03 EDT
0.81 EUR / 0.86 EUR +0.60% Intraday chart for DISCOUNT OPTIONSSCHEIN - CELSIUS HLDGS
Date Price Change
24-07-02 0.83 +1.22%
24-07-01 0.82 -1.20%
24-06-28 0.83 +1.22%
24-06-27 0.82 -2.38%
24-06-26 0.84 +1.20%

Delayed Quote Börse Stuttgart

Last update July 02, 2024 at 02:52 pm

More quotes

Static data

Product typeProductos Exóticos
Buy / SellPUT
Underlying CELSIUS HOLDINGS, INC.
Issuer Morgan Stanley
WKN MG4CZX
ISINDE000MG4CZX4
Date issued 2024-05-16
Strike 90 $
Maturity 2024-12-20 (171 Days)
Parity 10 : 1
Emission price 0.44
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 0.84
Lowest since issue 0.43
Spread 0.01
Spread %1.20%

Company Profile

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a fitness drink or supplement which, with exercise, is designed to accelerate metabolism and burn body fat while providing energy. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The Company also offers a new CELSIUS Essentials line, available in 16-ounce cans. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce. Additionally, the Company's products are also offered in certain Canadian, European, Middle Eastern and Asia-Pacific markets. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C.
Sector
-
More about the company

Ratings for Celsius Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

Consensus: Celsius Holdings, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
57.24 USD
Average target price
83.43 USD
Spread / Average Target
+45.76%
Consensus